EUROPEAN VASCULAR SURGERY TRADING LIMITED

EUROPEAN VASCULAR SURGERY TRADING LIMITED

EUROPEAN VASCULAR SURGERY TRADING LIMITED - Company Information

Print Friendly Version

EUROPEAN VASCULAR SURGERY TRADING LIMITED

Company Registration Number:
09481391 (England and Wales)

Unaudited abridged accounts for the year ended 31 December 2022

Period of accounts

Start date: 01 January 2022

End date: 31 December 2022

EUROPEAN VASCULAR SURGERY TRADING LIMITED

Contents of the Financial Statements

for the Period Ended 31 December 2022

Balance sheet
Notes

EUROPEAN VASCULAR SURGERY TRADING LIMITED

Balance sheet

As at 31 December 2022


Notes
2022
2021


£
£
Fixed assets
Investments: 3 1 1
Total fixed assets: 1 1
Current assets
Debtors:   301,120 206,954
Cash at bank and in hand:   94,812
Total current assets: 301,120 301,766
Creditors: amounts falling due within one year: 4 (301,120) (301,766)
Net current assets (liabilities): 0 0
Total assets less current liabilities: 1 1
Total net assets (liabilities): 1 1
Capital and reserves
Called up share capital: 1 1
Shareholders funds: 1 1

The notes form part of these financial statements

EUROPEAN VASCULAR SURGERY TRADING LIMITED

Balance sheet statements

For the year ending 31 December 2022 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with Section 444(2A).

These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

The directors have chosen to not file a copy of the company’s profit & loss account.

This report was approved by the board of directors on 20 June 2023
and signed on behalf of the board by:

Name: Dr Vincent Jongkind
Status: Director

The notes form part of these financial statements

EUROPEAN VASCULAR SURGERY TRADING LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2022

1. Accounting policies

These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

Turnover policy

Turnover is recognised when it is receivable under the terms of an associated contract.

Valuation and information policy

Investments are included at fair value.

EUROPEAN VASCULAR SURGERY TRADING LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2022

2. Employees

2022 2021
Average number of employees during the period 0 0

EUROPEAN VASCULAR SURGERY TRADING LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2022

3. Fixed investments

Investment in subsidiary at 1 January and 31 December 2022 - £1

EUROPEAN VASCULAR SURGERY TRADING LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2022

4. Creditors: amounts falling due within one year note

Other creditors £25,485 (2021: £6,713)Amounts owed to group undertakings £275,635 (2021: £295,053)Total £301,120 (2021: £301,766).

EUROPEAN VASCULAR SURGERY TRADING LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2022

5. Related party transactions

The company's ultimate and immediate parent is European Society for Vascular Surgery, a charitable company registered in England and Wales with registered office at 18 Saxon Way, Romsey, Hampshire, SO51 5PT. Its principal place of business is 275 Boulevard Albert 1er, 33130, Begles, France.